"hepatocellular cancer" trang 9 - tải miễn phí từ tailieuXANH
ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells

ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells
9    38    0
Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection

Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection
14    61    0
Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma

Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma
8    60    0
VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma

VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma
8    55    0
Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: A rationale for combining selective internal radiation therapy (SIRT) and immunotherapy

Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: A rationale for combining selective internal radiation therapy (SIRT) and immunotherapy
10    71    0
Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion

Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion
9    50    0
A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function

A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function
14    50    0
Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma

Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma
11    77    0
Single-stranded DNA binding protein 2 expression is associated with patient survival in hepatocellular carcinoma

Single-stranded DNA binding protein 2 expression is associated with patient survival in hepatocellular carcinoma
8    63    0
A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients

A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients
13    46    0
CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
10    51    0
SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
8    82    0
Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib

Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib
7    85    0
Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation

Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation
12    85    0
Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?

Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?
13    52    0
Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): A randomized controlled trial

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): A randomized controlled trial
11    40    0
First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: Preliminary results of safety, durable survival and immune biomarkers

First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: Preliminary results of safety, durable survival and immune biomarkers
11    53    0
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib

Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib
13    52    0
Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma: A single-arm meta-analysis based on prospective studies

Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma: A single-arm meta-analysis based on prospective studies
13    58    0
Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma

Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
10    53    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.